Supratek Pharma

Supratek is a private clinical-stage specialty pharmaceutical company took up to the invention and development of New Therapeutic Entities (NTE) through formulation design. Each NTE is an innovative chemotherapeutic agent that addresses satisfy needs of patients with cancer. Supratek is making approved drugs more efficient, safer, easier to use and more cost effective. They are using leading-edge BioMod™ and BioTrans™ platform technologies. All drug candidates and platform technologies are patent protected and are wholly owned by Supratek.